Natixis’s NeoGenomics NEO Stock Holding History

Natixis’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11K	Buy	+150	New	+$1.58K	﹤0.01%	1062
2025 Q4	–	Sell	-150	Closed	-$1.16K	–	1239
2025 Q3	$1.16K	Hold	150	–	–	﹤0.01%	1029
2025 Q2	$1.1K	Hold	150	–	–	﹤0.01%	993
2025 Q1	$1.36K	Hold	150	–	–	﹤0.01%	926
2024 Q4	$2.47K	Hold	150	–	–	﹤0.01%	987
2024 Q3	$2.21K	Hold	150	–	–	﹤0.01%	894
2024 Q2	$2.08K	Hold	150	–	–	﹤0.01%	927
2024 Q1	$2.36K	Hold	150	–	–	﹤0.01%	948
2023 Q4	$2.43K	Hold	150	–	–	﹤0.01%	976
2023 Q3	$1.84K	Sell	150 -151	-50%	-$2.25K	﹤0.01%	924
2023 Q2	$4.84K	Sell	301 -111	-27%	-$1.83K	﹤0.01%	953
2023 Q1	$7.17K	Sell	412 -51	-11%	-$727	﹤0.01%	905
2022 Q4	$4.28K	Buy	+463	New	+$4.32K	﹤0.01%	1023

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Natixis's NEO Position: Q1 2026 in Review

Natixis opened a new position in NeoGenomics (NEO) in Q1 2026: 150 shares worth $1.11K. The stake represents ﹤0.01% of the portfolio and ranks #1062 among its holdings. This is a return to the name: Natixis previously reported a position in NEO as recently as Q3 2025.

Natixis first reported a position in NEO in Q4 2022 and has held it in 13 quarters since. The position peaked at $7.17K in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Natixis held 150 shares of NeoGenomics worth $1.11K as of Q1 2026.
NeoGenomics was a new Natixis position in Q1 2026.
NeoGenomics made up ﹤0.01% of Natixis's portfolio in Q1 2026, its #1062 holding.
Natixis first reported a position in NeoGenomics in Q4 2022 and has held it in 13 quarters since.
Natixis's NeoGenomics position peaked at $7.17K in Q1 2023.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.